Releasing GeoFlow V2, the world’s first unified atomic foundation model for protein design.

Learn MoreIntroducing GeoFlow V2: Next-Generation Protein Foundation Model Unifying Structure Prediction and De Novo Design

BioGeometry, in collaboration with Jianwei Zhu’s team from Shanghai Jiao Tong University’s School of Pharmacy, achieved a remarkable increase in the neutralizing activity of the 8G3 antibody against the latest JN.1 virus variant, boosting it by 1000-1500 times in a short period.

Learn MorePNAS Publication: BioGeometry’s AI Boosts Antibody Neutralization Against New Virus Variants by 1000-Fold

BioGeometry’s generative AI model, GeoFlow, redesigns the hydrophobic regions of transmembrane proteins to be soluble in water while retaining their structure and function.

Learn MoreBreakthrough : BioGeometry’s AI-Driven Protein Design Revolutionizes Transmembrane Protein Solubilization and Drug Development

BioGeometry was honored with the “Computing Power Star” award for its breakthrough in denovo protein design using generative AI and geometric deep learning.

Learn MoreAwards | BioGeometry Named “Computational Power Star” for Technological Breakthroughs at 2024 China Computational Power Conference

This strategic partnership will leverage the strengths of both companies to advance innovative vaccine development and production, creating cutting-edge vaccines in China and contributing to global health.

Learn MoreBioGeometry and GeneVax Collaborate to Enhance Vaccine Design with Advanced Protein AI Models

BioGeometry and collaborators published a paper in Nature Communications, introducing the pre-trained geometric graph neural network GearBind and its application in antibody affinity maturation.

Learn MoreBioGeometry’s AI-Driven Method for Affinity Maturation Published in Nature Communications